Literature DB >> 7575468

Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S.

J S Munger1, C Haass, C A Lemere, G P Shi, W S Wong, D B Teplow, D J Selkoe, H A Chapman.   

Abstract

To investigate the potential contribution of the lysosomal compartment in the processing of amyloid precursor protein (APP) to amyloid beta-peptides (A beta s), we stably overexpressed a series of lysosomal proteases (the cysteine proteases, cathepsins B, L and S, and the aspartic protease, cathepsin D) in a human kidney epithelial cell line (293) transfected to express high levels of beta APP. Preliminary experiments indicated that 293 cells endogenously synthesize cathepsins B, L and D, but not cathepsin S. A beta secretion was assessed by immunoprecipitation and ELISA and found to be increased approximately 2-fold following cathepsin S expression, but to be unchanged (cathepsins B, L) or decreased (cathepsin D) in the other double transfectants. E-64d, an inhibitor of lysosomal cysteine proteases, significantly reduced A beta secretion by the cathepsin S transfectants, but had no effect on cells expressing the other proteases. Radiosequencing of A beta secreted by cathepsin S-expressing cells revealed that a previously unreported variant beginning at Met -1 (relative to the most common A beta N-terminus, Asp -1) accounted for most of the increase in A beta secretion. Immunostaining of human brain sections revealed cathepsin S in cortical neurons and glia in samples of brain from patients with Alzheimer's disease. These results provide evidence in living cells for a pathway in which cathepsin S generates A beta from amyloidogenic fragments of beta APP in the endosomal/lysosomal compartment. This pathway appears to be inducible, distinct from a constitutive pathway used by 293 and other cells to generate A beta, and may be relevant to the pathogenesis of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7575468      PMCID: PMC1136152          DOI: 10.1042/bj3110299

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  58 in total

1.  Sequence analysis, tissue distribution, and expression of rat cathepsin S.

Authors:  S Petanceska; L Devi
Journal:  J Biol Chem       Date:  1992-12-25       Impact factor: 5.157

2.  Phylogenetic conservation of cysteine proteinases. Cloning and expression of a cDNA coding for human cathepsin S.

Authors:  B Wiederanders; D Brömme; H Kirschke; K von Figura; B Schmidt; C Peters
Journal:  J Biol Chem       Date:  1992-07-05       Impact factor: 5.157

3.  A calcium-stimulated serine protease from monkey brain degrades the beta-amyloid precursor protein.

Authors:  B L Razzaboni; G Papastoitsis; E H Koo; C R Abraham
Journal:  Brain Res       Date:  1992-09-04       Impact factor: 3.252

4.  Human brain peptidase activity with the specificity to generate the N-terminus of the Alzheimer beta-amyloid protein from its precursor.

Authors:  J R McDermott; J A Biggins; A M Gibson
Journal:  Biochem Biophys Res Commun       Date:  1992-06-15       Impact factor: 3.575

5.  Amyloid beta-peptide is produced by cultured cells during normal metabolism.

Authors:  C Haass; M G Schlossmacher; A Y Hung; C Vigo-Pelfrey; A Mellon; B L Ostaszewski; I Lieberburg; E H Koo; D Schenk; D B Teplow
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

6.  The lysosomal cysteine protease, cathepsin S, is increased in Alzheimer's disease and Down syndrome brain. An immunocytochemical study.

Authors:  C A Lemere; J S Munger; G P Shi; L Natkin; C Haass; H A Chapman; D J Selkoe
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

7.  Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids.

Authors:  P Seubert; C Vigo-Pelfrey; F Esch; M Lee; H Dovey; D Davis; S Sinha; M Schlossmacher; J Whaley; C Swindlehurst
Journal:  Nature       Date:  1992-09-24       Impact factor: 49.962

8.  Molecular cloning and expression of human alveolar macrophage cathepsin S, an elastinolytic cysteine protease.

Authors:  G P Shi; J S Munger; J P Meara; D H Rich; H A Chapman
Journal:  J Biol Chem       Date:  1992-04-15       Impact factor: 5.157

9.  Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production.

Authors:  M Citron; T Oltersdorf; C Haass; L McConlogue; A Y Hung; P Seubert; C Vigo-Pelfrey; I Lieberburg; D J Selkoe
Journal:  Nature       Date:  1992-12-17       Impact factor: 49.962

10.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

Authors:  M Shoji; T E Golde; J Ghiso; T T Cheung; S Estus; L M Shaffer; X D Cai; D M McKay; R Tintner; B Frangione
Journal:  Science       Date:  1992-10-02       Impact factor: 47.728

View more
  21 in total

1.  Ex vivo cultures of microglia from young and aged rodent brain reveal age-related changes in microglial function.

Authors:  Emalick G Njie; Ellen Boelen; Frank R Stassen; Harry W M Steinbusch; David R Borchelt; Wolfgang J Streit
Journal:  Neurobiol Aging       Date:  2010-07-02       Impact factor: 4.673

2.  Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: neuropathologic evidence for a mechanism of increased beta-amyloidogenesis.

Authors:  A M Cataldo; J L Barnett; C Pieroni; R A Nixon
Journal:  J Neurosci       Date:  1997-08-15       Impact factor: 6.167

3.  Cathepsin S increases tau oligomer formation through limited cleavage, but only IL-6, not cathespin S serum levels correlate with disease severity in the neurodegenerative tauopathy progressive supranuclear palsy.

Authors:  Georg Nübling; M Schuberth; K Feldmer; A Giese; L M Holdt; D Teupser; S Lorenzl
Journal:  Exp Brain Res       Date:  2017-05-10       Impact factor: 1.972

4.  Cerebrospinal fluid cathepsin B and S.

Authors:  Elin Nilsson; Constantin Bodolea; Torsten Gordh; Anders Larsson
Journal:  Neurol Sci       Date:  2012-03-23       Impact factor: 3.307

5.  Neurotrophic factors regulate cathepsin S in macrophages and microglia: A role in the degradation of myelin basic protein and amyloid beta peptide.

Authors:  J P Liuzzo; S S Petanceska; L A Devi
Journal:  Mol Med       Date:  1999-05       Impact factor: 6.354

Review 6.  Regulation of the alternative β-secretase meprin β by ADAM-mediated shedding.

Authors:  Franka Scharfenberg; Fred Armbrust; Liana Marengo; Claus Pietrzik; Christoph Becker-Pauly
Journal:  Cell Mol Life Sci       Date:  2019-06-14       Impact factor: 9.261

Review 7.  Transglutaminase 2: Friend or foe? The discordant role in neurons and astrocytes.

Authors:  Breandan R Quinn; Laura Yunes-Medina; Gail V W Johnson
Journal:  J Neurosci Res       Date:  2018-03-23       Impact factor: 4.164

8.  Microglial activation varies in different models of Creutzfeldt-Jakob disease.

Authors:  C A Baker; Z Y Lu; I Zaitsev; L Manuelidis
Journal:  J Virol       Date:  1999-06       Impact factor: 5.103

9.  Association studies of 22 candidate SNPs with late-onset Alzheimer's disease.

Authors:  Jessica A Figgins; Ryan L Minster; F Yesim Demirci; Steven T Dekosky; M Ilyas Kamboh
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-06-05       Impact factor: 3.568

Review 10.  Cysteine cathepsins in neurological disorders.

Authors:  Anja Pišlar; Janko Kos
Journal:  Mol Neurobiol       Date:  2013-11-15       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.